Osteoarthritis: Aging of Matrix and Cells - Going for a Remedy
The DOI matches its Crossref record.
Abstract
It has been known for a very long time that aging is the most prominent risk factor for the initiation and progression of osteoarthritis. This might be related to continuous mechanical wear and tear and/or result from time/age-related modifications of cartilage matrix components. Also a mere loss of viable cells over time, due to apoptosis or any other mechanism, might contribute. More recent evidence, however, supports that stressful conditions for the cells might promote chondrocyte senescence and might be in particular important for the progression of the osteoarthritic disease process. One of the most important implications of this hypothesis is that it points to issues of cellular degeneration as the basis for understanding of the initiation and the progression of osteoarthritis. Equally important, it emphasizes that whatever treatment we envisage for osteoarthritis, we must take into account that we are dealing with aged/(pre)senescent cells which no longer have the abilities of their juvenile counterparts to respond to the many mechanical, inflammatory, and traumatic assaults to the tissue. Thirdly, this directs treatment options to deal with the senescence of cells, which are only conceptually available today. Clearly, if accumulation of wear and tear over time is the major scenario of osteoarthritis, any therapy will largely be hopeless as moving and loading the joints is unavoidable as implication of their use. However, this review intends to open up the idea that age-related changes are less a fate, but rather a challenge for therapeutic intervention which can be taken.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment with GLP-1RAs can effectively mitigate chondrocyte apoptosis caused by endoplasmic reticulum stress and alleviate the associated inflammatory response.277–280”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [277]
Citations
Cites
Still being checked.
Cited by
Goldring, M. B., & Goldring, S. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21258 · Cited by 1,179
“These changes in the material properties of cartilage have been attributed to changes in the structural organization of the ECM (Dudhia, 2005; Loeser, 2006; Aigner et al., 2007).”
BackgroundGlucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Cartilage homeostasis in health and rheumatic diseases
Goldring, M. B., & Marcu, K. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2592 · Cited by 762
Caramés, B., Taniguchi, N., Otsuki, S., Blanco, F. J., & Lotz, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27305 · Cited by 632
“Many factors can be implicated in the development of OA, but one of the most important risk factors is aging (4).”
BackgroundMajor biological obstacles for persistent cell-based regeneration of articular cartilage
Steinert, A. F., Ghivizzani, S. C., Rethwilm, A., Tuan, R. S., Evans, C. H., & Nöth, U. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2195 · Cited by 321
Metadata
- Authors
- Aigner, T., Haag, J., Martin, J., & Buckwalter, J.
- Affiliations
- Leipzig University (DE)
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-02-01
- Volume
- 8
- Issue
- 2
- Pages
- 325-331
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2114263381
- Cited by
- 85
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 7 · 2013: 11 · 2012: 7
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- osteoarthritis, aging, chondrocyte senescence, cartilage matrix, apoptosis, cell degeneration, wear and tear, senolytic therapy, osteoarthritis treatment
- MeSH terms
- Adolescent, Adult, Aged, Cartilage, Articular, Extracellular Matrix, Humans, Middle Aged, Osteoarthritis, Cellular Senescence, Glycation End Products, Advanced, Chondrocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoarthritis: Aging of Matrix and Cells - Going for a Remedy. https://app.cochat.ai/papers/10.2174/138945007779940070
- The paper
- Aigner, T., Haag, J., Martin, J., & Buckwalter, J. (2007). Osteoarthritis: Aging of Matrix and Cells - Going for a Remedy. Current Drug Targets. https://doi.org/10.2174/138945007779940070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.